Literature DB >> 3737641

Mecamylamine blockade of nicotine responses: evidence for two brain nicotinic receptors.

A C Collins, C B Evans, L L Miner, M J Marks.   

Abstract

Mice of two inbred strains, DBA and C3H, were pretreated with mecamylamine before challenge with nicotine. Mecamylamine blocked nicotine-induced seizures, enhanced startle, and alterations in respiratory rate, Y-maze activity, heart rate and body temperature. Mecamylamine blocked nicotine-induced seizures and enhanced startle with IC50 values of less than 0.1 mg/kg. The other nicotine effects were blocked by mecamylamine with IC50 values between 0.8 and 2.3 mg/kg. Strain differences in sensitivity to mecamylamine blockade were also detected. These results suggest that nicotine elicits its effects at two receptors, which may be those labeled with [125I]-alpha-bungarotoxin and with [3H]-nicotine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3737641     DOI: 10.1016/0091-3057(86)90518-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  13 in total

1.  Discriminative stimulus effects of mecamylamine and nicotine in rhesus monkeys: Central and peripheral mechanisms.

Authors:  Colin S Cunningham; Megan J Moerke; Lance R McMahon
Journal:  Pharmacol Biochem Behav       Date:  2019-02-06       Impact factor: 3.533

2.  Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.

Authors:  Nick C Ortiz; Heidi C O'Neill; Michael J Marks; Sharon R Grady
Journal:  Nicotine Tob Res       Date:  2012-01-12       Impact factor: 4.244

Review 3.  Nicotine and smoking: a perspective from animal studies.

Authors:  P B Clarke
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 4.  Green tobacco sickness: mecamylamine, varenicline, and nicotine vaccine as clinical research tools and potential therapeutics.

Authors:  Lance R McMahon
Journal:  Expert Rev Clin Pharmacol       Date:  2019-01-24       Impact factor: 5.045

5.  Alpha4beta2 nicotinic receptor stimulation contributes to the effects of nicotine in the DBA/2 mouse model of sensory gating.

Authors:  Richard J Radek; Holly M Miner; Natalie A Bratcher; Michael W Decker; Murali Gopalakrishnan; Robert S Bitner
Journal:  Psychopharmacology (Berl)       Date:  2006-05-06       Impact factor: 4.530

6.  Nicotine decreases DNA methyltransferase 1 expression and glutamic acid decarboxylase 67 promoter methylation in GABAergic interneurons.

Authors:  R Satta; E Maloku; A Zhubi; F Pibiri; M Hajos; E Costa; A Guidotti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-13       Impact factor: 11.205

7.  Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.

Authors:  P B Clarke; M Reuben
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

8.  The effect of chronic nicotine treatment on nicotine-induced seizures.

Authors:  L L Miner; A C Collins
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 9.  Thymopoietin, a thymic polypeptide, potently interacts at muscle and neuronal nicotinic alpha-bungarotoxin receptors.

Authors:  M Quik
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

10.  Effects of nicotine on the acoustic startle reflex amplitude in rats.

Authors:  J B Acri; N E Grunberg; D E Morse
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.